Greyson International, Inc. Receives Its Issue Date and Patent Number from the U.S. Patent and Trademark Office for its Breakthrough Trilexon® Delivery System Technology

Coconut Creek, Fla. – August 30, 2012– Greyson International, Inc. (GYSN.PK) announced today that it has received its issue date and Patent number from the U.S. Patent and Trademark Office.  The Patent will be issued on September 18, 2012 and the Patent Number is 8,268,335.

The Trilexon® Delivery System Technology, allows active ingredients to work for a longer period of time than other products currently available on the market, and therefore produces results never before possible. The Trilexon® delivery system can improve the effectiveness of virtually every topical application in almost any field imaginable.

Greyson International CEO, Harvey Tauman, said “We are very confident that this patent will support us in moving forward with marketing and licensing agreements wherever active ingredients are needed. This trans-dermal delivery system could be used more effectively in cosmetic, medical and veterinary use.”

The patent is classified as a “Utility” patent and, according to the US Patent Office; a utility patent is only obtained when the invention is for a “new and useful process, machine, manufacture, or composition of matter.”

About Greyson International, Inc.

Greyson International, Inc. is a research, development and marketing company that markets health and beauty aid products. Trilexon® is a registered trademark of Greyson International. For more information, visit; join the Greyson Facebook group page by visiting

This release contains information about management’s view of our future expectations, plans and prospects that constitute forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from historical results or those indicated by these forward-looking statements as a result of a variety of factors including, but not limited to, risks and uncertainties associated with our financial condition, our ability to sell our products and our ability to compete with competitors. We encourage you to review other factors that may affect our future results on any current or future documents we file periodically with the Securities & Exchange Commission.


Harvey Tauman

Greyson International Inc.

Chief Executive Officer

(954) 482-0497


† Trilexon® is a registered trademark of Greyson International, Inc.


Recommended Posts